Ursodeoxycholic acid is considered as first line treatment in patients with primary biliary cirrhosis. Its mechanism of action in this disease is unknown and there is controversy about its clinical impact. Searching in Epistemonikos database, which is maintained by screening 19 databases, we identified four systematic reviews including 16 studies. We combined the evidence using tables with summary of findings following the GRADE approach and concluded ursodeoxycholic acid may not have any effect on pruritus, and there is uncertainty about its effect on mortality, need for liver transplantation or on any other important outcome for the patient
To establish the efficacy of combination therapy with ursodeoxycholic acid (UDCA) and colchicine in ...
Recent clinical studies have indicated that ursodeoxycholic acid (ursodiol), administered at dosages...
Background & Aims: The clinical efficacy of ursodeoxycholic acid (UDCA) in primary biliary chola...
Abstract The administration of ursodeoxycholic acid, a hydrophilic bile acid not hepatotoxic to hum...
The administration of ursodeoxycholic acid, a hydrophilic bile acid not hepatotoxic to humans, has b...
A review is made of the literature regarding the present status of ursodeoxycholic acid in the treat...
Abstract: Aim: To establish the efficacy of combination therapy with ursodeoxycholic acid (UDCA) and...
BACKGROUND: It is uncertain whether ursodeoxycholic acid therapy slows down the progression of prima...
To evaluate the effect of ursodeoxycholic acid (UDCA) treatment according to the severity of primary...
BACKGROUND: Ursodeoxycholic acid (UDCA) improves liver function tests and prolongs survival in prima...
Background & AimsWe evaluated the efficacy and safety of obeticholic acid (OCA, α-ethylchenodeoxycho...
Different bile acids have different effects on liver cells, depending on the degree of hydroxylation...
BACKGROUND/AIM: In randomised controlled trials (RCTs) of ursodeoxycholic acid (UDCA), although seru...
Ursodeoxycholic acid has been reported to be of potential benefit for primary sclerosing cholangitis...
BACKGROUND & AIMS: Ursodeoxycholic acid (UDCA) improves laboratory liver test results in patients wi...
To establish the efficacy of combination therapy with ursodeoxycholic acid (UDCA) and colchicine in ...
Recent clinical studies have indicated that ursodeoxycholic acid (ursodiol), administered at dosages...
Background & Aims: The clinical efficacy of ursodeoxycholic acid (UDCA) in primary biliary chola...
Abstract The administration of ursodeoxycholic acid, a hydrophilic bile acid not hepatotoxic to hum...
The administration of ursodeoxycholic acid, a hydrophilic bile acid not hepatotoxic to humans, has b...
A review is made of the literature regarding the present status of ursodeoxycholic acid in the treat...
Abstract: Aim: To establish the efficacy of combination therapy with ursodeoxycholic acid (UDCA) and...
BACKGROUND: It is uncertain whether ursodeoxycholic acid therapy slows down the progression of prima...
To evaluate the effect of ursodeoxycholic acid (UDCA) treatment according to the severity of primary...
BACKGROUND: Ursodeoxycholic acid (UDCA) improves liver function tests and prolongs survival in prima...
Background & AimsWe evaluated the efficacy and safety of obeticholic acid (OCA, α-ethylchenodeoxycho...
Different bile acids have different effects on liver cells, depending on the degree of hydroxylation...
BACKGROUND/AIM: In randomised controlled trials (RCTs) of ursodeoxycholic acid (UDCA), although seru...
Ursodeoxycholic acid has been reported to be of potential benefit for primary sclerosing cholangitis...
BACKGROUND & AIMS: Ursodeoxycholic acid (UDCA) improves laboratory liver test results in patients wi...
To establish the efficacy of combination therapy with ursodeoxycholic acid (UDCA) and colchicine in ...
Recent clinical studies have indicated that ursodeoxycholic acid (ursodiol), administered at dosages...
Background & Aims: The clinical efficacy of ursodeoxycholic acid (UDCA) in primary biliary chola...